文献速递湿疹皮炎与荨麻疹

婴儿早期直接紫外线暴露与湿疹及免疫发育的批判性评价

Direct infant ultraviolet light exposure is associated with eczema and immune development: a critical appraisal.
PubMed 文献 · Br J Dermatol · 2019-07-22

维生素D组与安慰剂组湿疹无差异,但探索性分析显示湿疹婴儿紫外线暴露中位数更低,且紫外线暴露与部分免疫标志物呈负相关。

要点

  • 高危婴儿补充维生素D提高水平但未降低湿疹风险。
  • 非随机子集分析中,湿疹婴儿紫外线暴露中位数低于无湿疹婴儿。
  • 紫外线暴露与TLR配体诱导的IL-2、GM-CSF和eotaxin产生呈负相关。

核心结论

  • 高危婴儿补充维生素D未减少湿疹发生。
  • 非随机探索性分析提示更多直接紫外线暴露与湿疹减少相关。
  • 作者认为早期紫外线暴露可能比维生素D补充更有益于过敏预防。

研究设计与样本

  • 双盲随机安慰剂对照试验,195名有first-degree relative with atopic disease的婴儿随机接受每日400 iU维生素D滴剂或安慰剂滴剂。
  • 在3、6月龄评估湿疹和喘息,6月龄评估25项免疫功能标志物。

主要发现

  • 维生素D组在3和6月龄维生素D水平显著高于安慰剂组。
  • 有湿疹婴儿紫外线暴露中位数555 J m-2,无湿疹婴儿中位数998 J m-2。
  • 紫外线暴露与Toll样受体配体诱导的interleukin-2、granulocyte macrophage colony-stimulating factor和eotaxin产生呈负相关。

临床怎么用

  • 对于有特应性疾病家族史的高危婴儿,补充维生素D不能预期降低湿疹风险。
  • 直接紫外线暴露与湿疹减少的关联来自非随机探索性分析,不能作为临床推荐依据。

局限性

  • 紫外线暴露分析为非随机探索性事后分析,样本量有限。
  • 紫外线暴露与湿疹的关联不能推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Rueter et al. aimed to 'determine the effects of early postnatal vitamin D supplementation on infant eczema and immune development'. SETTING AND DESIGN: This was a double-blind randomized placebo-controlled trial with an additional nonrandomized exploratory analysis on the effects of ultraviolet (UV) exposure led from a hospital setting. STUDY EXPOSURE: Vitamin D (400 iU daily) drops or placebo drops (coconut and palm kernel oil) were allocated randomly to 195 infants born to families with a first-degree relative with atopic disease. Eighty-six of these infants were allocated personal UV dosimeters in a nonrandomized fashion to measure UV light (290-380 nm) exposure until 3 months of age. OUTCOMES: Eczema and wheeze were assessed at 3 and 6 months, and 25 immune function markers were assessed at 6 months of age. Infant vitamin D levels and immune functions were measured at 6 months of age. RESULTS: Although vitamin D levels were significantly greater in infants in the intervention group than in those in the placebo group at 3 and 6 months of age, there was no difference in eczema between groups at either time point (10·0% vs. 6·7% at 3 months and 21·8 vs. 19·3% at 6 months for the vitamin D and placebo groups, respectively). In the subset of infants given a dosimeter, those with eczema had less UV light exposure (median 555 J m-2 ) than infants who did not develop eczema (median 998 J m-2 ). Across the 25 immune functions, UV light exposure was inversely correlated with interleukin-2, granulocyte macrophage colony-stimulating factor and eotaxin production by Toll-like receptor ligands. CONCLUSIONS: Vitamin D supplementation in high-risk infants increased vitamin D levels but did not reduce eczema. Exploratory post-hoc analyses in a nonrandomized subset showed an association between greater direct UV light exposure and reduction of eczema. The authors claim that their 'findings indicate that UV light exposure appears more beneficial than vitamin D supplementation as an allergy prevention strategy in early life'.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Maslin D, Veitch D, Williams HC, et al. Direct infant ultraviolet light exposure is associated with eczema and immune development: a critical appraisal. Br J Dermatol. 2019. PMID: 31054159. doi:10.1111/bjd.18087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。